KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Short term Debt: 2021

Historic Short term Debt for TherapeuticsMD (TXMD) over the last 1 years, with Dec 2021 value amounting to $188.3 million.

  • TherapeuticsMD's Short term Debt rose 524.01% to $93.6 million in Q3 2022 from the same period last year, while for Sep 2022 it was $93.6 million, marking a year-over-year increase of 524.01%. This contributed to the annual value of $188.3 million for FY2021, which is N/A change from last year.
  • Per TherapeuticsMD's latest filing, its Short term Debt stood at $188.3 million for FY2021.
  • TherapeuticsMD's 5-year Short term Debt high stood at $188.3 million for FY2021, and its period low was $188.3 million during FY2021.
  • For the 1-year period, TherapeuticsMD's Short term Debt averaged around $188.3 million, with its median value being $188.3 million (2021).